Gyeongnam Pharmaceutical Healthcare Designated as a Non-Compliant Disclosure Corporation
[Asia Economy Reporter Han Jinju] The Korea Exchange KOSDAQ Market Division announced on the 20th that it will designate Gyeongnam Pharmaceutical Healthcare as a non-compliant disclosure corporation due to the reversal of a disclosure related to the termination of a single sales and supply contract.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Woman Experiences Eye Protrusion After 20 Years of Contraceptive Injections, Plans Lawsuit Against Major Pharmaceutical Company
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The designation as a non-compliant disclosure corporation will take effect on the 21st. The penalty points imposed are 6 points, and Gyeongnam Pharmaceutical's total penalty points for non-compliant disclosure corporations over the past year (including the current penalty points) amount to 64.8 points.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
